New Approach to Treating Melanoma

An international research team, led by Professor Wenbo Bu of Fudan University and Distinguished Professor Dayong Jin of the University of Technology Sydney, discovered an innovative method to effectively treat cancer by reactivating suppressed metabolic pathways in cancer cells, as published in the prestigious journal Nature Nanotechnology.

cancer cells, nanomedicine

Image Credit: crystal light/Shutterstock.com​​​​​​​

The researchers employed tyrosine, a common amino acid, as a nanomedicine to alter the metabolism of melanoma, a fatal skin cancer, and prevent the disease from spreading.

Australia has the highest skin cancer rate in the world. This novel technique could be coupled with existing therapies to improve the treatment of melanoma. The approach could potentially be used to treat other forms of cancer.

Tyrosine’s bioavailability is restricted in living beings. However, the researchers employed a novel nanotechnology approach to packaging it into small particles known as nanomicelles. These particles are attracted to cancer cell membranes and rapidly break down, increasing absorption.

The researchers then tested the novel therapy in mice and human-derived melanoma cells in the lab, discovering that the tyrosine nanomicelles awoke dormant metabolic pathways, induced melanin formation, and suppressed tumor development.

Uncontrolled rapid growth is a key feature that distinguishes cancer cells from normal cells. In cancer cells some metabolic pathways are over-activated, and others are suppressed, to create the environment necessary for rapid spread.

Dayong Jin, Distinguished Professor, University of Technology Sydney

He added, “While a few metabolism-based drugs for cancer have been developed previously, such as aromatase inhibitors impeding estrogen synthesis in breast cancer and HK2 inhibitors targeting glycolysis in various cancers, these work by suppressing over-activate metabolic pathways.

Professor Bu noted, “Our research shows for the first time that cancer can be stopped by reactivating metabolic pathways that are dormant. And this can be done using simple nutrients, such as amino acids, sugars, and vitamins, which are safe, readily available and well tolerated.

Different nutrients will have varying effects on cancer. Melanoma cells arise from melanocytes, which are skin cells that create melanin. Tyrosine is required to create melanin and can enhance melanin production, which explains its effectiveness with melanoma.

The reactivation of melanin synthesis causes the melanoma cell to lower glycolysis, the process of turning sugar into energy, which is believed to be the reason for its anti-cancer effects.

Melanoma cells are also susceptible to heat stress. The researchers discovered that by combining tyrosine nanomicelle therapy with near-infrared laser treatment, they could remove melanoma in mice within six days, and it did not return during the study time.

The findings point to a possible fresh frontier in using nanomedicine for cancer treatment.

Journal reference:

Chen, Y. et al. (2024) Nutrient-delivery and metabolism reactivation therapy for melanoma. Nature Nanotechnology. doi:10.1038/s41565-024-01690-6

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combination immunotherapy yields 10-year survival for metastatic melanoma patients